Clinical Trial Detail

NCT ID NCT00976573
Title Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Indications

melanoma

Therapies

Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Carboplatin + Everolimus + Paclitaxel

Age Groups: adult senior

No variant requirements are available.